ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article
Revised

Assessment of perioperative bleeding in pediatric osteogenesis imperfecta patients undergoing orthopedic surgeries: A single-center study

[version 2; peer review: 2 approved with reservations]
PUBLISHED 17 Feb 2025
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Manipal Academy of Higher Education gateway.

Abstract

Background

“Osteogenesis imperfecta (OI)” is a heterogeneous group of inherited disorders involving collagen type I with a 10–30% incidence of bleeding diathesis placing these individuals at an increased risk of bleeding. Our study aims to ascertain the risk factors that increase the propensity of perioperative blood transfusions in pediatric population.

Methods

A single center retrospective observational study of patients aged <18 years undergoing orthopedic surgeries at our tertiary care hospital from January 2016 to August 2024 were included and each surgery was analyzed as a discrete event. Age, type of OI, number of osteotomies, and number of bones operated simultaneously were recorded. The fall in hemoglobin, requirement for blood transfusions and associated factors were analyzed.

Results

Amongst 53 individuals who underwent surgery, 141 procedures were analyzed. The mean age was 11.07± 5.29 years, majority (n=33;62.2%) were phenotypically type III OI, and 42/53 (79%) patients underwent multiple osteotomies. Significant hemoglobin fall was observed after surgery (p<0.001) and was considerable in patients undergoing various osteotomies (p=0.002). Older children showed a smaller drop in hemoglobin level. Patients with type III OI showed significant hemoglobin fall (1.82 ± 0.86 g/dL). The transfusion requirement was seen in 23 (16.3%) surgeries besides it was significant in those undergoing multiple osteotomies (p= <0.05).

Conclusion

Our study inferred that the fall in hemoglobin was significant postoperatively in OI patients and was associated with younger age, type III OI, and multiple osteotomies. Before performing orthopedic surgeries on patients with OI, surgeons might consider the latter risk factors to explore therapeutic options aimed at reducing hemorrhage and improving outcomes.

Keywords

Bleeding diathesis, Osteogenesis imperfecta, Osteotomies, Perioperative bleeding

Revised Amendments from Version 1

The newer version highlights the use of intraoperative anti-fibrinolytic agent (local or intravenous) to reduce the bleeding incidence in cases with osteogenesis imperfecta and recommends its use for the same.

See the authors' detailed response to the review by Hesham Mohamed Elbaseet

Introduction

“Osteogenesis imperfecta (OI)” also known as “brittle bone disease” is a rare congenital disease resulting from a defect in the type I collagen synthesis or processing with an incidence of 1:20000. It has a wide spectrum of presentations ranging from almost asymptomatic to severe forms causing increased bone fragility, skeletal deformity, and a range of extra-skeletal manifestations.1 Majority of the OI patients have pathogenic mutations in “COL1A1 or COL1A2” genes which code for alpha 1 and 2 chains of type I collagen which are abundant in bones, ligaments, and tendons. Collagen type 1 is produced less frequently and/or abnormally in dominant pathogenic variations. It is commonly known that the variation type, precise location, and implicated gene all affect the phenotypic presentation of these patients.2

Numerous mutations linked to OI have been found; however, missense mutations mostly cause structural changes in the collagen protein, which results in a more severe phenotype, whereas stop mutations typically result in decreased collagen quantity and a mild phenotype.3 OI is well known for its clinical manifestations, which include blue sclera, hearing loss, ligament laxity, increased joint mobility, small stature, easy bruising, and normal enamel with dentin abnormalities. Bony manifestations include bone abnormalities, fractures from minor trauma, and the requirement for repeated orthopedic treatments.3

OI is also associated with easy bruising and bleeding, often attributed to the increased fragility of capillaries and perivascular connective tissue that cannot constrict adequately. The clotting abnormalities in OI patients can be explained due to reduced collagen-induced platelet aggregation response surrounding the exposed sub endothelium, reduced platelet retention, and reduced levels of factor VIII.4,5 Previous research has also shown enlarged platelets, diminished retention of platelets, and decreased factor VIII (FVIII) as the possible reasons for the bleeding manifestation.6,7

However, in OI patients even with normal coagulation profile, bleeding might still happen, which makes intraoperative bleeding unpredictable.8,9 The literature review revealed no studies involving the pediatric population in India and a few Western studies analyzing the perioperative blood loss in pediatric OI patients undergoing orthopedic surgeries. In a retrospective analysis of 23 OI patients, aged between 6 and 13 years, who underwent osteosynthesis for femoral shaft fractures or correction of femoral deformities, Persiani et al.10 from Italy identified predictive risk factors regarding intraoperative bleeding, revealing that patients affected by type III OI have a high risk of severe blood loss during surgery. Similarly, a study conducted in the United States by Pichard et al.11 examined a retrospective review of 22 pediatric OI patients who had 42 surgeries involving the insertion of 52 femoral rods. The results indicated that an increase in osteotomies was associated with an increase in adjusted mean blood loss (P = 0.05). Therefore, having access to autologous blood donations or a sufficient supply of blood products will help address the potential issue of increased perioperative blood loss, a crucial component of treatment, while organizing the care of patients with OI. Therefore, the purpose of this study is to determine the variables influencing perioperative blood loss and need for blood transfusion in pediatric OI patients undergoing osteotomies.

Methods

This was a retrospective case-record-based study conducted in pediatric OI patients who underwent osteotomies at a tertiary care hospital. The research conducted in this study adhered to the principles outlined in the Declaration of Helsinki and was approved by the Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee (IEC 363/2024) on 18th September 2024. A waiver of consent was granted as per our institutional ethics committee due to the retrospective nature of the study. Individual patient anesthesia records, daily progress notes, initial history, physical examination, and doctor instructions from each hospital stay were obtained through electronic records and analyzed. Variables in terms of age, type of OI, single or multiple osteotomies were collected. Additionally, hematologic parameters such as transfusion history, hemoglobin before and after surgery, and hemoglobin at discharge when available were collected. The factors associated with fall in hemoglobin postoperatively and requirement of blood transfusions were analyzed.

Statistical analysis

Discrete variables are represented as frequencies and percentages. Continuous data are shown as mean±SD. A chi-squared test was performed to assess the association between the parameters. Statistical significance was set at p <0.05. The data were analyzed using SPSS version 29.

Results

During our study period, 53 patients who underwent a total of 141 procedures during their stay in hospital were analyzed and each surgery was analyzed as a discrete event. Their mean age was 11.07±5.29 years; 4/53 (7.8%) were phenotypically type I OI, the majority (n=33; 62.2%) were phenotypically type III OI and the remaining 16/53 (30%) were type IV OI. 61/141 (43.3%) surgeries involved a single bone, and 80/141 (56.7%) surgeries involved multiple bones. Of 53 patients requiring osteotomies, 11/53 underwent once, 9/53 underwent twice, 17/53 (majority) underwent thrice, 7/53 underwent four times, 4/53 underwent five times, 3/53 underwent six times and only 2/53 underwent osteotomies seven times ( Table 1).

Table 1. Baseline characteristics.

Characteristics n=53 (141 surgeries)
Age (in years; Mean±SD)11.07±5.29 years
Type of OI (phenotype)Type I – 4 (7.8%)
Type III – 33 (62.2%)
Type IV – 16 (30%)
Osteotomy n (%)Single – 61 (43.3%)
Multiple – 80 (56.7%)
Frequency of osteotomies n (%)Once – 11
2 times – 9
3 times – 17
4 times – 7
5 times – 4
6 times – 3
7 times – 2

  • A. Drop in hemoglobin

    • 1. During this study, it was noted that the fall in hemoglobin was statistically significant with multiple osteotomies (p=0.002) when compared to single osteotomy (p=0.297), and the total fall in hemoglobin between the pre-operative (12.22±1.06 g/dL) and post-operative (10.57±1.48 g/dL) period was also statistically significant (p≤0.001) ( Table 2).

    • 2. During our study, we noted that the hemoglobin drop significantly correlated with the age of the patients. Statistical analysis with a scatterplot diagram confirmed that as the age of our study population advanced the fall in hemoglobin reduced ( Figure 1).

    • 3. In this study, type III OI was associated with significant hemoglobin drop (p=0.01) ( Table 3) and post-hoc pairwise analysis (Kruskal Wallis testing) also confirmed that the hemoglobin fall was significantly associated with type III OI (p=0.008) when compared to other types of OI ( Table 4).

  • B. Requirement of blood transfusion

    • 1. In this study, no blood transfusion was required in 58 single osteotomy and 60 multiple osteotomies (n=118; 83.7%). However, 3 single osteotomies and 20 multiple osteotomies required blood transfusions (n=23; 16.3%) which was statistically significant (p=0.001) ( Table 5; Figure 2).

    • 2. There was no significant correlation noted between age of the patient and the need for blood transfusions.

    • 3. In this study, we also analyzed the type of OI and requirement of transfusion, which showed that in 9 type I OI undergoing surgeries none required transfusion; in type III OI, 73 surgeries did not require transfusion and 15 surgeries required transfusion; in type IV OI, 36 surgeries did not require transfusion and 8 surgeries required transfusion, however none were significant (p=0.387) ( Table 5).

Table 2. Surgery and fall in hemoglobin.

Hb dropPre-surgery Hb (g/dL)Post-surgery Hb (g/dL) p-value
After single osteotomy10.68±1.4410.42±1.540.297
After multiple osteotomies12.52±1.0711.98±0.990.002*
Total12.22±1.0610.57±1.48<0.001*

* Significant p-value.

74a9a46c-ae2a-4049-8925-2ccd78aaea5b_figure1.gif

Figure 1. Hemoglobin drop vs age of the patient.

Table 3. Type of OI and hemoglobin drop.

Type of OI (n)Hb(g/dL) Mean ± SD p-value
Type I (4)1.12±0.570.01*
Type III (83)1.82±0.86
Type IV (40)1.19±0.58

* Significant p-value.

Table 4. Post-hoc analysis (pairwise comparison).

Type I- Type IV1.000
Type I- Type III0.250
Type IV- Type III0.008*

* Significant p-value.

Table 5. Requirement of blood transfusion.

CharacteristicTransfusion requirement p-value
NoYes
Operated on
 Single bone5830.001 *
 Multiple Bone6020
Type of OI
 I900.387
 III7315
 IV368

* Significant p-value.

74a9a46c-ae2a-4049-8925-2ccd78aaea5b_figure2.gif

Figure 2. Difference in requirement of transfusion between single or multiple bone surgeries.

Discussion

“Osteogenesis imperfecta” is a broad category of hereditary collagen type I diseases. Bony deformities, heart valvular lesions, cognitive abnormalities, and metabolic disturbances are frequently linked to OI. In addition to defective collagen synthesis, patients with OI have increased capillary fragility, decreased platelet retention, decreased levels of factor VIII, and deficient collagen-induced platelet aggregation that causes excessive bruising and widespread oozing from wound sites, thus surgical procedures performed on these patients are more likely to result in bleeding complications despite normal coagulation parameters which makes assessment of perioperative blood loss unpredictable and is of a major concern to the surgeons.2,3,5

In this study, 53 patients who underwent a total of 141 surgeries were analyzed (an average of 3 surgeries per patient) during their stay in hospital and each surgery was analyzed as a separate event. Their mean age was 11.07±5.29 years, the majority (n=33; 62.2%) were phenotypically type III OI, and 80/141 (56.7%) surgeries involved multiple bones. This is similar to the study by Ruck et al.,12 who conducted a retrospective analysis of 60 OI children undergoing femoral rodding, showed a mean age of 4 years which is lower when compared to our study, however, the majority (n=30/60) had type III OI which is similar to our study. The study by Persiani et al.10 was conducted on 23 patients aged between 6 and 13 years (mean - 8.9±1.9 years) affected by type III OI, wherein 42 osteotomies were done, and the majority (n=11/23) underwent an average of 3 osteotomies which is similar to our study.

Our study showed a greater fall in hemoglobin in patients with multiple osteotomies done simultaneously (p=0.002) when compared to a single osteotomy and also the total fall in hemoglobin post-operatively was statistically significant (p≤0.001) which is similar to the study done by Persiani et al.10 that showed average effective blood loss increased significantly as the number of osteotomies increased (p=0.046). Thus, the use of a structured bleeding survey is more advantageous than laboratory measurements as there is little correlation between the severity of bleeding with the levels of a particular factor, and the standard tests do not accurately reflect in vivo hemostasis due to the unmeasurable contribution of numerous factors (such as vessel fragility or fibrinolysis).1315

This study revealed a negative correlation between the age of the patients and a fall in hemoglobin, suggesting that older children had better tolerance for blood loss when compared to a younger age group. Similar findings were reported in the study by Pichard et al.,11 which involved a retrospective review of 22 patients. The oldest patient, who underwent surgery, was 21 years and 2 months old, and the youngest, who underwent surgery, was 1 year and 7 months old. Of the 42 surgeries examined, the mean blood loss was 197 cc, with older patients generally having lower adjusted mean blood loss, though this difference was not statistically significant (p=0.07). The most likely explanation offered is that while a larger bone’s radius of diameter and, hence, its area of bleeding may cause more bleeding, a larger patient with a larger total blood volume may be able to withstand more bleeding.11

In this study, type III OI showed a significant hemoglobin drop (1.82±0.86 g/dL; p=0.01) and post hoc analysis also confirmed that the hemoglobin fall was significantly associated with type III OI (p=0.008) when compared to the other types of OI which are similar to the study by Persiani et al.10 wherein patients affected by type III OI had a high risk of severe blood loss during surgery. The probable explanation is that type III OI is characterized by increased capillary fragility and an altered platelet function caused by platelet dysfunction due to alteration in collagen when compared to other types of OI.

The perioperative transfusion requirement in surgeries for OI patients was found to be 23/141 surgeries (16.3%) in this study. Our study is similar to the study by Pichard et al.11 wherein six blood transfusions were given with a transfusion rate of 14%. The study under reference revealed that the average blood loss among transfused patients was 279 cc. Additionally, patients who underwent transfusion had an adjusted blood loss of 0.330 as opposed to those who did not get blood transfusion, who had an adjusted blood loss of only 0.003. Our findings are in line with studies by Gooijer et al.16 and Oakley et al.,17 which found that 17% of OI patients needed blood transfusions following surgery. For this reason, it is crucial to be aware of the bleeding risk. Despite a normal pre-operative hematological assessment, several studies1821 describe severe bleeding in OI patients as a result of surgery, thus in patients with OI, “American Society of Anesthesiologists transfusion guidelines” state, “platelet transfusion may be indicated despite an adequate platelet count if there are known platelet dysfunction and microvascular bleeding.” “Bleeding time and platelet aggregation tests are not useful in the operating room”, and “there is an urgent need for the development of clinically relevant measures of in vivo platelet function and bleeding risk to guide the rational use of platelet transfusion”.

Our study showed incidence of transfusion was higher in those who underwent multiple osteotomies simultaneously (p=0.001) which is similar to the study by Persiani et al.10 wherein the perioperative transfusion requirement was more in type III OI but not statistically significant (p=0.387). These results were comparable to those of research by Hathaway et al.22 and others,23,24 which discovered aberrant platelet adhesion, poor platelet factor 3 (PF3) release, aberrant platelet aggregation to ADP, and commonly faulty platelet aggregation in type III OI patients, thus corroborating with our finding of increased transfusion requirement in type III OI patients. Since the relationship between genotype and phenotype is frequently less strict than previously believed due to variability in penetrance and expressivity, coinheritance of hemostatic defects, or superimposed genetic modifiers, a genomic search for the molecular basis of inherited clotting and platelet defects may not be as beneficial.15 When regular hemostasis testing revealed no repeatable anomaly in a group of individuals with a significant history of bleeding, Obaji et al.25 administered tranexamic acid or desmopressin, and they observed no bleeding in 90% of the patients at high risk of bleeding receiving an intervention which can be used in OI patients as well before surgery to reduce the bleeding incidence post operatively. Yet another prospective randomized controlled study by Elbaseet HM et al.26 wherein patients with osteogenesis imperfecta undergoing femoral telescoping nail the use of tranexamic acid (local or intravenous) intraoperatively revealed a significant decrease in blood loss, thus supporting the use of antifibrinolytic agents in these patients.

Limitations

  • 1. Single-center study.

  • 2. Surgical time and duration of hospitalization were not recorded.

  • 3. Average blood loss during surgery was not quantified.

Conclusion

The most reliable indicators of perioperative bleeding and the need for transfusion in procedures involving OI patients were the patient’s age, the type of OI, and the number of osteotomies. Surgeons evaluating bleeding tendency in OI patients need to take these particular parameters into account to potentially prevent hemorrhagic consequences and improve overall outcomes.

Ethics and consent statement

The research followed the tenets of the Declaration of Helsinki. The institutional ethical committee namely Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee (IEC 542/2019) approved all study protocols (IEC 363-2024) on 18th September 2024. A waiver of consent was granted as per our institutional ethics committee due to the retrospective nature of the study.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 25 Nov 2024
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Kulkarni M, Shah HH, subbiah S et al. Assessment of perioperative bleeding in pediatric osteogenesis imperfecta patients undergoing orthopedic surgeries: A single-center study [version 2; peer review: 2 approved with reservations]. F1000Research 2025, 13:1420 (https://doi.org/10.12688/f1000research.158583.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 17 Feb 2025
Revised
Views
1
Cite
Reviewer Report 02 Jun 2025
Vivek Kumar Morya, Hallym University Dongtan Sacred Heart Hospital, Dongtan, South Korea 
Approved with Reservations
VIEWS 1
This single-center retrospective observational study investigates perioperative bleeding and the need for blood transfusions in pediatric osteogenesis imperfecta (OI) patients undergoing orthopedic surgeries. The study analyzed 141 procedures in 53 patients (mean age 11.07±5.29 years) from January 2016 to ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Morya VK. Reviewer Report For: Assessment of perioperative bleeding in pediatric osteogenesis imperfecta patients undergoing orthopedic surgeries: A single-center study [version 2; peer review: 2 approved with reservations]. F1000Research 2025, 13:1420 (https://doi.org/10.5256/f1000research.178083.r383091)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 25 Nov 2024
Views
11
Cite
Reviewer Report 05 Feb 2025
Hesham Mohamed Elbaseet, Assiut University, Asyut, Assiut Governorate, Egypt 
Approved with Reservations
VIEWS 11
Thanks for your effort in writing the manuscript. Please add and / or modify the following:

1- A lot of cited  references are out of date (one of them was 1971) please use recent references.
2- ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Elbaseet HM. Reviewer Report For: Assessment of perioperative bleeding in pediatric osteogenesis imperfecta patients undergoing orthopedic surgeries: A single-center study [version 2; peer review: 2 approved with reservations]. F1000Research 2025, 13:1420 (https://doi.org/10.5256/f1000research.174199.r363165)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 17 Feb 2025
    Sushma Thimmaiah Kanakalakshmi, Department of Anesthesiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, 576104, India
    17 Feb 2025
    Author Response
    Response to comments:
    Many thanks for reviewing our manuscript. We have made the suggested changes and resubmitted a revised version for your reference.
    Comment:
    1- A lot of cited  references ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 17 Feb 2025
    Sushma Thimmaiah Kanakalakshmi, Department of Anesthesiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, 576104, India
    17 Feb 2025
    Author Response
    Response to comments:
    Many thanks for reviewing our manuscript. We have made the suggested changes and resubmitted a revised version for your reference.
    Comment:
    1- A lot of cited  references ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 25 Nov 2024
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.